Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy.
We describe an open study of macrogol 3350 in 10 cases of constipated patients with Parkinson's disease or multiple system atrophy. The agent produced a marked improvement in symptoms in all cases.
Eichhorn
T E
TE
Department of Neurology, Philipps University Marburg, Marburg, Germany.
Oertel
W H
WH
D000368:Aged; D002400:Cathartics / Q000627:therapeutic use*; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D004573:Electrolytes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000150:complications*; D010300:Parkinson Disease / Q000150:complications*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D016896:Treatment Outcome
D002400:Cathartics; D004573:Electrolytes; D011092:Polyethylene Glycols